Skip to main content
. Author manuscript; available in PMC: 2022 Sep 21.
Published in final edited form as: Nat Biotechnol. 2022 Mar 3;40(8):1270–1275. doi: 10.1038/s41587-022-01232-2

Figure 4. Antibody neutralization of SARS-CoV-2 variants.

Figure 4.

Authentic SARS-CoV-2 neutralization for a panel of antibodies is shown against USA-WA1 and variants (Alpha, Beta, Gamma, and Delta). Data represent the % neutralization as mean ± SD. The IC50 values calculated in GraphPad prism software by 4-parameter best-fit analysis are shown to the right of the panel.